Given that SUR1 and SUR2 subunits are well-established drug targets in diabetes and cardiovascular diseases, the high expression of KATP channel subunits in the colon suggests their potential for pharmacological modulation of intestinal motility and barrier function. Here, ABCC9 is linked to cardiovascular disorder.